2
BASULI ET AL.
methanol and was evaporated at 70°C to 80°C. The residue
was dissolved in the appropriate solvent, and the resulting
Macherey‐Nagel (Düren, Germany) and the packing mate-
rial was reduced to half (~20 mg). Luna (2) C18 column
(10 × 250 mm, 5 μm) was obtained from Phenomenex
(Torrance, CA, USA). Other columns and all other Sep‐
Pak cartridges used in this synthesis were obtained from
Agilent Technologies (Santa Clara, CA, USA) and Waters
(Milford, MA, USA), respectively. Oasis MCX Plus car-
tridge was conditioned by passing 5‐mL acetonitrile. Sep‐
Pak plus C18 cartridges were conditioned with 5‐mL eth-
anol, 10‐mL air, and 10‐mL water. Low resolution mass
spectra (MS) were recorded on a 6130 Quadrupole LC/
MS, Agilent Technologies instrument equipped with a
18
solution was heated to obtain labeled aldehydes. The [ F]
fluorobenzaldehyde, thus prepared using different methods,
were used for a variety of coupling reactions to radiolabel a
3
,4
wide range of biomolecules.
18
[
F]Fluorobenzaldehydes are also used in the
synthesis of maleimide functionalized fluorine‐18 labeling
agents, another important class of radiolabeling synthons
for site specific labeling of biomolecules via coupling with a
thiol group. A variety of fluorine‐18 labeled maleimide func-
tionalized prosthetic groups have been developed over the
18
1
13
19
last few years, eg, 2‐[ F]fluoronicotinaldehyde O‐(6‐(2,5‐
diode array detector. H, C, and F NMR spectra were
recorded on a 400‐MHz Bruker spectrometer. Chemical
shifts (ppm) are reported relative to the solvent residual
1
8
12
dihydro‐1H‐pyrrol‐1‐yl)hexyl) oxime ([ F]FBAMPy), N‐[2‐
18
18
13,14
(
4‐[ F]fluorobenzamido)ethyl]maleimide ([ F]FBEM),
N‐[6‐ (4‐ [ F]fluorobenzylidene)aminooxyhexyl]maleimide
[ F]FBAM), [ F]FDG‐maleimidehexyloxime ([ F]FDG‐
1‐[3‐(2‐[ F]fluoropyridin‐3‐oxy)propyl]maleimide
and N‐(2‐(2,5‐dioxo‐2,5‐dihydro‐1H‐
pyrrol‐1‐yl)‐ethyl)‐6‐fluoronicotinamide ([ F]FNEM).
18
1
13
peaks of acetonitrile (δ H, 2.50 ppm; C 118.26, 1.79),
1
8
15 18
18
1
1
(
methanol (δ H, 3.34 ppm), and chloroform (δ H,
7.26 ppm). F NMR spectra are reported with reference
to the trifluoroacetic acid (δ F, −76.72 ppm). High perfor-
16
18
19
MHO),
1
8
17,18
19
(
[ F]FPyME),
18
19
mance liquid chromatography (HPLC) purification and
analytical HPLC analyses for radiochemical work were per-
formed on an Agilent 1200 Series instrument equipped with
multi‐wavelength detectors along with a flow count
radiodetector (Eckert & Ziegler, B‐FC‐3500 diode).
HPLC conditions:
Preparation of any of these compounds requires a 2‐
step or 3‐step synthesis with overall preparation times
ranging from 60 to 90 minutes. The objective of this work
is to improve the radiosynthesis of a maleimide
functionalized radiolabeling agents by using our newly
developed “Radiofluorination on the Sep‐Pak” method.
18
Herein, we report rapid synthesis of 6‐[ F]
Method A; Column: Phenomenex Luna (2) C18 column
(10 × 250 mm, 5 μm). Mobile phase: A: water (0.1%
TFA); B: acetonitrile (0.1% TFA). Isocratic: 45% B;
flow rate of 4 mL/min.
18
fluoropyridinealdehyde ([ F]5) and its coupling with a
maleimide functionalized amino‐oxy ligand to produce a
18
useful synthon ([ F]6) for site‐specific radiolabeling of
biomolecules in 30 minutes of total synthesis time.
Method B; Column: Agilent XDB C18 column
(
4.6 × 150 mm, 5 μm). Mobile phase: A: water (0.1%
TFA); B: acetonitrile (0.1% TFA). Gradient: 20% to
40% B in 10 minutes; flow rate of 1 mL/min.
Method C; Column: Agilent XDB C18 column
(4.6 × 150 mm, 5 μm). Mobile phase: A: water (0.1%
TFA); B: acetonitrile (0.1% TFA). Isocratic: 60% B;
flow rate of 1 mL/min.
2
| MATERIALS AND METHODS
The precursor 4‐formyl‐N,N,N‐trimethylanilinium trifluoro-
methanesulfonate (1) was purchased from ABX advanced
biochemical compounds (Radeberg, Germany). The non‐
radioactive cold standard 6‐fluoropyridinealdehyde was
obtained from Sigma Aldrich (St. Louis, MO, USA).
The precursor 6‐(N,N,N‐trimethylamino)nicotinaldehyde
2.1 | Precursors and cold standard
2
.1.1 | 6‐(N,N,N‐trimethylamino)
nicotinaldehyde trifluoromethanesulfonate
Scheme 1, 2)
19
trifluoromethanesulfonate (2),
1‐(6‐(aminooxy)hexyl)‐
and non‐radioactive cold stan-
dard of fluorine‐18 labeled maleimide derivative,
fluoronicotinaldehyde O‐(6‐(2,5‐dioxo‐2,5‐dihydro‐1H‐
13,20
1
H‐pyrrole‐2,5‐dione
(
The precursor was synthesized according to the literature
13
pyrrol‐1‐yl)hexyl) oxime, FPyMHO (6), were synthesized
by literature methods. All other chemicals and solvents
were received from Sigma Aldrich (St. Louis, MO, USA)
and used without further purification. Anhydrous solvents
were used for all radiolabeling reactions. Fluorine‐18 was
received from National Institutes of Health cyclotron facil-
method using 6‐chloronicotinaldehyde instead of 2,3,5,6‐
19
tetrafluorophenyl 6‐chloronicotinate.
Briefly, to a
tetrahydrofuran (THF, 2 mL) solution of 6‐chloro-
nicotinaldehyde (1.4 g, 9.9 mmol) under nitrogen was
added 1 M THF solution of trimethylamine (11 mL,
11 mmol), and the reaction was stirred at room tempera-
ture for 24 hours. The off‐white precipitate thus obtained
was collected and washed with cold (4°C) THF. The solid
ity (Bethesda, MD, USA). Chromafix 30‐PS‐HCO anion‐
exchange Sep‐Pak cartridges were purchased from
3